Management of NAFLD involves weight loss, controlling metabolic syndrome and treating dyslipedemia. This retrospective study looks at effect of dietary advice and lipid lowering drugs, particularly statins, on patients with NAFLD and dyslipedemia.
This study concludes that weight loss is associated with a lowering of serum ALT levels in NAFLD, and that the use of statins to treat concurrent dyslipidaemia is efficacious and does not lead to a significant deterioration in serum ALT.
My previous post on NAFLD is worth browsing through.
0 comments:
Post a Comment